HomeCompareDTARF vs MRK

DTARF vs MRK: Dividend Comparison 2026

DTARF yields 1408.45% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTARF wins by $396181116.90M in total portfolio value
10 years
DTARF
DTARF
● Live price
1408.45%
Share price
$0.14
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$396181116.95M
Annual income
$347,628,612,125,698.30
Full DTARF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — DTARF vs MRK

📍 DTARF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTARFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTARF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTARF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTARF
Annual income on $10K today (after 15% tax)
$119,718.31/yr
After 10yr DRIP, annual income (after tax)
$295,484,320,306,843.56/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, DTARF beats the other by $295,484,320,298,515.10/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTARF + MRK for your $10,000?

DTARF: 50%MRK: 50%
100% MRK50/50100% DTARF
Portfolio after 10yr
$198090558.51M
Annual income
$173,814,306,067,748.22/yr
Blended yield
87.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DTARF
No analyst data
Altman Z
-89.5
Piotroski
0/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTARF buys
0
MRK buys
0
No recent congressional trades found for DTARF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTARFMRK
Forward yield1408.45%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$396181116.95M$56.8K
Annual income after 10y$347,628,612,125,698.30$9,798.13
Total dividends collected$392623552.61M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DTARF vs MRK ($10,000, DRIP)

YearDTARF PortfolioDTARF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$151,545$140,845.07$11,206$366.19+$140.3KDTARF
2$2,156,955$1,994,801.51$12,650$502.35+$2.14MDTARF
3$28,842,699$26,534,757.71$14,407$694.19+$28.83MDTARF
4$362,470,620$331,608,932.15$16,585$967.82+$362.45MDTARF
5$4,282,591,462$3,894,747,898.48$19,342$1,363.89+$4282.57MDTARF
6$47,588,408,428$43,006,035,563.10$22,913$1,947.19+$47588.39MDTARF
7$497,541,651,942$446,622,054,924.38$27,662$2,823.89+$497541.62MDTARF
8$4,896,368,656,645$4,363,999,089,067.01$34,159$4,173.35+$4896368.62MDTARF
9$45,376,172,736,896$40,137,058,274,285.76$43,337$6,308.80+$45376172.69MDTARF
10$396,181,116,954,177$347,628,612,125,698.30$56,776$9,798.13+$396181116.90MDTARF

DTARF vs MRK: Complete Analysis 2026

DTARFStock

Delta Resources Limited, an exploration company, engages in the acquisition, exploration, and development of gold and base metal projects in Canada. It has an agreement to acquire a 100% interest in the Delta-1/Eureka project, which consists of 245 mining claims totaling an area of 4,495 hectares located in the Thunder Bay district of Ontario; and the Delta-2 project comprising 237 claims covering an area of 12,650 hectares located in the Chibougamau Mining district of Quebec. The company also holds an option agreement to acquire the Dollier property that consists of 40 claims covering an area of 2,228 hectares located in Chibougamau, Quebec. The company was formerly known as Golden Hope Mines Limited and changed its name to Delta Resources Limited in July 2019. Delta Resources Limited was incorporated in 1946 and is based in Kingston, Canada.

Full DTARF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DTARF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTARF vs SCHDDTARF vs JEPIDTARF vs ODTARF vs KODTARF vs MAINDTARF vs JNJDTARF vs ABBVDTARF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.